Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Context: With age, the prevalence of subclinical hypothyroidism rises. However, incidence and determinants of spontaneous normalization remain largely unknown.
Objective: To investigate incidence and determinants of spontaneous normalization of TSH levels in older adults with subclinical hypothyroidism.
Design: Pooled data were used from the (1) pretrial population and (2) in-trial placebo group from 2 randomized, double-blind, placebo-controlled trials (Thyroid Hormone Replacement for Untreated Older Adults With Subclinical Hypothyroidism Trial and Institute for Evidence-Based Medicine in Old Age thyroid 80-plus thyroid trial).
Setting: Community-dwelling 65+ adults with subclinical hypothyroidism from the Netherlands, Switzerland, Ireland, and the United Kingdom.
Participants: The pretrial population (N = 2335) consisted of older adults with biochemical subclinical hypothyroidism, defined as ≥1 elevated TSH measurement (≥4.60 mIU/L) and a free T4 within the laboratory-specific reference range. Individuals with persistent subclinical hypothyroidism, defined as ≥2 elevated TSH measurements ≥3 months apart, were randomized to levothyroxine/placebo, of which the in-trial placebo group (N = 361) was included.
Main Outcome Measures: Incidence of spontaneous normalization of TSH levels and associations between participant characteristics and normalization.
Results: In the pretrial phase, TSH levels normalized in 60.8% of participants in a median follow-up of 1 year. In the in-trial phase, levels normalized in 39.9% of participants after 1 year of follow-up. Younger age, female sex, lower initial TSH level, higher initial free T4 level, absence of thyroid peroxidase antibodies, and a follow-up measurement in summer were independent determinants for normalization.
Conclusion: Because TSH levels spontaneously normalized in a large proportion of older adults with subclinical hypothyroidism (also after confirmation by repeat measurement), a third measurement may be recommended before considering treatment.
Trial Registration: ClinicalTrials.gov, NCT01660126 and Netherlands Trial Register, NTR3851.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10876405 | PMC |
| http://dx.doi.org/10.1210/clinem/dgad623 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Effects of Maternal Iodine Deficiency in Women with Mild Thyroid Dysfunction During Early Pregnancy on Mental and Motor Growth of Their Offspring During Levothyroxine Treatment.
Biol Trace Elem Res
September 2025
Department of Endocrinology and Metabolism, Institute of Endocrinology, Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Affiliated Hospital of China Medical University, No. 155 in Nanjing North Street, Heping Distinct, Shenyang, 110001, P. R. China.
The relationship between maternal thyroid function and intellectual development of offspring is controversial. Iodine may be an important confounding factor. This study investigated whether maternal iodine status could affect the efficacy of levothyroxine (LT4) treatment during early pregnancy on the intellectual growth of progeny.
View Article and Find Full Text PDFBackground: Thyroid dysfunction commonly coexists with type 2 diabetes mellitus (T2DM), compounding metabolic derangements and increasing the risk of complications. Despite its clinical significance, the prevalence and spectrum of thyroid dysfunction among South Asian patients with T2DM remain incompletely characterized. This study aimed to determine the frequency and types of thyroid dysfunction in patients with T2DM and to examine its associations with demographic characteristics, glycemic control, metabolic parameters, and microvascular complications.
View Article and Find Full Text PDFCorrelation analysis of thyroid function and vitamin D levels in patients with type 2 diabetes.
Front Endocrinol (Lausanne)
September 2025
Department of Endocrinology and Metabolism, the Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Background: This study investigated the association between vitamin D status and thyroid function in 1,805 adults with type 2 diabetes mellitus (T2DM) treated at a tertiary hospital between 2018 and 2024. We analyzed demographic, metabolic, and thyroid function parameters to determine whether vitamin D levels influence thyroid dysfunction in this population.
Methods: Plasma 25-hydroxyvitamin D, thyroid hormones (FT3, FT4, TSH), and autoantibodies (TPOAb, TGAb, TRAb) were measured using electrochemiluminescence.
Discordance between knee and hand-wrist bone age in adolescents: implications for skeletal maturity assessment and its association with thyroid-stimulating hormone levels.
Pediatr Radiol
September 2025
Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, No.1 Shuaifuyuan, Dongcheng District, Beijing, 100730, China.
Background: Hand-wrist radiographs may not fully reflect skeletal bone age (BA) during mid-to-late puberty. Knee magnetic resonance imaging (MRI), a non-radiative imaging technique, may provide detailed evaluation of the lower limbs.
Objective: To validate the San Diego MRI-based knee BA atlas in a Chinese adolescent cohort presenting with growth deceleration, evaluate the concordance between knee and hand-wrist BA, and explore factors influencing potential discrepancies.
Hashimoto's thyroiditis in children and adolescents: analysis of long-term course.
J Pediatr Endocrinol Metab
September 2025
Department of Pediatric Endocrinology, University of Health Science Umraniye Training and Research Hospital, Istanbul, Türkiye.
Objectives: This study retrospectively evaluated long-term clinical and biochemical findings in children and adolescents diagnosed with Hashimoto thyroiditis (HT).
Methods: A total of 233 patients aged 2-18 years, diagnosed with HT and followed for at least three years, were included. Patients were classified into five subgroups based on thyroid stimulating hormone (TSH) and free thyroxine (fT4) levels at diagnosis.